Diabetic retinopathy and systemic vascular complications

被引:179
|
作者
Cheung, Ning [1 ,2 ]
Wong, Tien Y. [1 ,2 ,3 ]
机构
[1] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia
[2] Royal Victorian Eye & Ear Hosp, Melbourne, Vic 3002, Australia
[3] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore Eye Res Inst, Singapore 117595, Singapore
关键词
retinopathy; stroke; heart failure; coronary heart disease; nephropathy; complications; microvascular disease; macrovascular disease; cardiovascular disease prediction; mortality;
D O I
10.1016/j.preteyeres.2007.12.001
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Retinopathy is the most common complication of diabetes. The assessment of retinopathy signs presents clinicians a unique opportunity to directly visualize and assess the actual morphology of diabetic microvascular damage. Extensive studies have now shown that people with diabetic retinopathy have excess risks of systemic vascular complications, including subclinical and clinical stroke, coronary heart disease, heart failure, and nephropathy. There is also emerging evidence to suggest that diabetic retinopathy may share common genetic linkages with systemic vascular complications. The extant literature, therefore, supports the theory that diabetic retinopathy reflects widespread microcirculatory disease not only in the eye but also vital organs elsewhere in the body. Being a uniquely specific and non-invasively assessable measure of diabetic microvascular damage, retinopathy may also be envisioned as a novel biomarker of vascular disease risk in asymptomatic patients with diabetes. This review summarizes recent studies on the systemic associations of diabetic retinopathy, and discusses their pathophysiological significance and clinical implications. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:161 / 176
页数:16
相关论文
共 50 条
  • [41] Neuronal and vascular segregation reveals the impact of systemic hypertension on peripapillary RNFL thickness in diabetic patients without diabetic retinopathy
    Schmetterer, Leopold
    Wong, Damon
    Yow, AiPing
    Tan, Bingyao
    Hussain, Rahat
    Chua, Jacqueline
    [J]. ACTA OPHTHALMOLOGICA, 2022, 100
  • [42] Genes for systemic vascular complications are differentially expressed in the livers of Type 2 diabetic patients
    Takamura, T
    Sakurai, M
    Ota, T
    Ando, H
    Honda, M
    Kaneko, S
    [J]. DIABETOLOGIA, 2004, 47 (04) : 638 - 647
  • [43] Genes for systemic vascular complications are differentially expressed in the livers of Type 2 diabetic patients
    T. Takamura
    M. Sakurai
    T. Ota
    H. Ando
    M. Honda
    S. Kaneko
    [J]. Diabetologia, 2004, 47 : 638 - 647
  • [44] The Role of Systemic Risk Factors in Diabetic Retinopathy
    Atchison E.
    Barkmeier A.
    [J]. Current Ophthalmology Reports, 2016, 4 (2) : 84 - 89
  • [45] Role of systemic risk factors in diabetic retinopathy
    Burany, L.
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2009, 14 : 73 - 74
  • [46] The Relationship Between Diabetic Retinopathy and Systemic Factors
    Demir, Ayse Keyser
    Alirn, Sait
    [J]. JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2014, 5 (06) : 530 - 536
  • [47] Florid diabetic retinopathy and its systemic implications
    Lanzetta, P
    Bandello, F
    Menchini, U
    Brancato, R
    [J]. DIABETES NUTRITION & METABOLISM, 1999, 12 (06) : 418 - 419
  • [48] Fenofibrate - A Potential Systemic Treatment for Diabetic Retinopathy?
    Wong, Tien Yin
    Simo, Rafael
    Mitchell, Paul
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 154 (01) : 6 - 12
  • [49] Retinal neurodegeneration in diabetic retinopathy with systemic hypertension
    Jae-Yun Sung
    Jae-Jun Kim
    Jae-Yul Hwang
    Min-Woo Lee
    [J]. Acta Diabetologica, 2024, 61 : 495 - 504
  • [50] SYSTEMIC MEDICATIONS FOR THE PREVENTION AND TREATMENT OF DIABETIC RETINOPATHY
    Stewart, M.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A129 - A129